Cannara Biotech Inc (LOVE) — Cash Flow Quality Index
Cannara Biotech Inc (LOVE) has a Cash Flow Quality Index of 7.66x as of November 2025. Operating cash flow of CA$7.96 Million exceeds net income of CA$1.04 Million, indicating high earnings quality where cash backs reported profits. Also explore Cannara Biotech Inc assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cannara Biotech Inc Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Cannara Biotech Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LOVE intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Cannara Biotech Inc (2022–2025)
Year-by-year earnings quality comparison for Cannara Biotech Inc. For live market cap and the full company financial profile, see market value of Cannara Biotech Inc.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.53x | CA$20.01 Million | CA$13.08 Million | ▼ -7.8% |
| 2024 | 1.66x | CA$10.68 Million | CA$6.44 Million | ▲ +95.0% |
| 2023 | 0.85x | CA$5.91 Million | CA$6.95 Million | ▲ +132.3% |
| 2022 | -2.64x | CA$-6.08 Million | CA$2.31 Million | — |